Ecuador Pharmaceutical Serialization and Traceability Compliance

Discover OneScan

Global Regulations

Summary

Ecuador regulates pharmaceutical products through the National Agency for Regulation, Control and Health Surveillance (ARCSA). The country has established requirements to strengthen medicine identification and improve traceability across the pharmaceutical supply chain.

The regulatory framework focuses on standardized product identification using GS1 barcodes and the capture of product data to support traceability and product verification. The objective is to reduce counterfeit medicines and improve regulatory visibility of pharmaceutical distribution.

Manufacturers, importers, and distributors supplying medicines to Ecuador must ensure pharmaceutical products include standardized barcode identification and maintain traceability records throughout the distribution chain.

Labelling Requirements 

Pharmaceutical products marketed in Ecuador must include barcode identification that supports product traceability.

The barcode used on secondary packaging typically follows GS1 standards and contains key product identification information.

Common data elements included in the barcode are:

  • GTIN
  • Batch Number
  • Expiry Date

The barcode enables identification of the product during distribution and dispensing operations.

Human readable product information printed on packaging must match the encoded barcode data.

Serialization of individual medicine packs using unique serial numbers is not currently mandated nationwide.

‍

Regulatory Timeline 

2012 – ARCSA established to regulate medicines, medical devices, and other health products in Ecuador.

2014 onward – Strengthening of pharmaceutical supply chain oversight and traceability requirements through labeling and identification standards.

Ongoing – Continued monitoring and regulatory initiatives to improve medicine supply chain security.

‍

Reporting Requirements 

Operation
Data to Report
When to Report
Product Registration
Product information submitted to ARCSA
Before market authorization
Batch Identification
Batch number and expiry date
During manufacturing and packaging
Import Documentation
Product identification and batch information
During importation
Distribution Records
Batch level shipment and distribution information
During supply chain transfers
Recall Reporting
Batch identification and distribution records
During recall or safety investigation

Traceability requirements focus on batch level product identification rather than individual pack serialization.

Operational Timelines for Industry 

  • Register pharmaceutical products with ARCSA before placing medicines on the Ecuadorian market.
  • Ensure packaging includes standardized barcode identification aligned with GS1 practices.
  • Maintain batch level traceability records for manufacturing, importation, and distribution.
  • Ensure distributors maintain shipment documentation that allows tracking of product batches.
  • Maintain recall readiness by ensuring distribution records are accurate and accessible.
  • Provide traceability information to ARCSA during regulatory inspections or product safety investigations.

Reporting Hub

Ecuador does not currently operate a nationwide pharmaceutical serialization repository that requires serial level reporting of supply chain events.

Traceability is supported through:

  • Product identification using standardized barcodes
  • Supply chain documentation maintained by manufacturers and distributors
  • Regulatory oversight conducted by ARCSA

Companies must maintain traceability documentation that allows regulators to identify product batches and distribution pathways when required.

Aggregation Requirements 

There is no regulatory requirement for aggregation or serialized packaging hierarchies in Ecuador.

Manufacturers and distributors may implement logistics identifiers such as SSCC internally to support warehouse operations and shipment tracking.

Aggregation practices are typically used for operational efficiency rather than regulatory compliance.

Common Errors to Avoid 

  • Failure to include standardized barcode identification on pharmaceutical packaging.
  • Mismatch between barcode data and printed product information.
  • Incomplete distribution records that prevent effective product recall.
  • Using inconsistent product identifiers across regulatory filings and packaging.
  • Failure to maintain batch level traceability documentation across the distribution network.

Trusted by Industry Leaders

Smooth and Successful

LSPedia didn’t just provide software; they ensured we were fully compliant. Anytime we had questions, the LSPedia team knew DSCSA inside and out and guided us step by step. That level of expertise made a huge difference during audits. Thanks to their expert team our audit was smooth and successful

Hussein Salman
Lead Pharmacist, Pioneer Pharmacy Services

Constant Commitment

LSPedia shows a constant commitment to improvement; whether it's their support or their product...they're always leveling up. The support team provides consistently thorough follow-up and clear, articulate communication. the support we receive represents a meaningful step up in service and is genuinely appreciated.

Zac Sweeny
EPCIS Data Encoder,Capital Wholesale Drug
Read All TestimonialsView Our Customers

Get in Touch

We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.

Contact Us